Smart Pharmaceutical Assistance: AI-Based Medication Risk Assessment System for Kidney Disease

Meeting & Discussion

Technology Introduction:
Technical Innovation: Weak AI–powered medication analysis, integration with commercial medical databases, and automated processes.
Competitive Property Advantage: Independently developed by hospital pharmacists, the system is grounded in solid clinical evidence and real-world application.
Key Achievements / Awards: 2024 National Quality Award (Taiwan)
Industry Applicability:
This AI-powered system supports medication interpretation for CKD patients, analyzing prescriptions and comorbidities. Integrating medical databases, it offers one-click drug interaction screening with risk assessments and solutions. Usable across hospitals, clinics, and pharmacies, it evaluates medication risks, delivers personalized recommendations, and promotes holistic patient care.

Zuoying Armed Forces General Hospital

Our hospital was established in the 1949 year of the Republic of China and has a history of over 70 years. In the early days, we only had clinical departments such as internal medicine, surgery, obstetrics and gynecology, and ophthalmology. After undergoing multiple organizational changes, we still uphold the core values of loyalty, responsibility, and treating patients as family. We continuously strive for improvement and growth, enhancing medical quality and the environment. Over the years, both our software and hardware have been expanded. Currently, we have 29 clinical departments, a total of 616 beds, and more than 897 employees. We are the only regional teaching hospital in the Zuonan area.